Our Physicians

Home > Physicians > Ilyas Khan

Ilyas Khan, M.D.

Ilyas Khan

Contact & Location

Lufkin

Phone: 936-632-8787

Heart Institute of East Texas
310 Gaslight Boulevard
Lufkin, TX 75904

San Augustine

Phone: 936-275-1303

Heart Institute of East Texas
904 West Columbia Street
San Augustine, TX 75972

Specialty

Board Certified Interventional Cardiologist

Board Certified in Cardiovascular Diseases, Echocardiography, Nuclear Cardiology, and Internal Medicine

Special Interests/Procedures

Coronary and Peripheral vascular disease management and interventions, valvular heart disease, heart failure, preventive cardiology.

Education & Credentials

Interventional Cardiology Fellowship at Lankenau Medical Center, Philadelphia, PA

Cardiovascular Diseases Fellowship at Lankenau Medical Center, Philadelphia, PA

Internal Medicine Residency at Lankenau Medical Center, Philadelphia, PA

Membership of Royal Colleges of Physicians from United Kingdom

Medical degree from Osmania Medical College in India

Practicing Since 2014

Insurances Accepted

Most insurances accepted

CHI St. Luke’s Health, HIET Offer New Technology for Blockages

CHI St. Luke’s Health, HIET Offer New Technology for Blockages

Lufkin cardiologists are using new technology to help patients with reoccurring blockages in the heart and legs.

Implanting stents to open obstructed blood vessels is an important treatment for patients suffering from Coronary and Peripheral Artery Disease (CAD/PAD). However, restenosis, a return of the blockage, can be very common. Ilyas Khan, M.D., Interventional Cardiologist with the Heart Institute of East Texas, introduced an innovative cardiovascular therapy to resolve this issue when he performed the first laser atherectomy at CHI St. Luke’s Health-Memorial this month.

Laser atherectomy, a vaporizing technology that breaks down stubborn blockages in the blood stream, represents an exciting alternative – one that alters the cycle of re-occlusion and improves clinical outcomes for patients. CHI St. Luke’s Health now offers the only FDA-cleared atherectomy technology for the treatment of in-stent restenosis (ISR), which has been clinically proven safer and superior in treating peripheral ISR.  

“We are constantly seeking new ways to improve the health of our patients by offering new technology that is less invasive, lowers their overall risk, and in most cases, lets them go home from the hospital the very same day as the procedure,” Dr. Khan said. “The new laser atherectomy procedure does all of that, and we are excited to use this technology more often in the future.”

More than 115,000 people in the United States suffer from ISR each year. When arteries become blocked due to disease, implanting stents is a common method to restore blood flow. But, within a year of stenting, ISR, or a return of blockage, occurs to some extent in 40% to 60% of cases.

“By launching our new laser atherectomy program, we advance our commitment to delivering unprecedented cardiovascular care by arming physicians with innovations that improve outcomes for patients and save lives and limbs from the threat of amputation,” said CHI St. Luke’s Health-Memorial Market COO Shawn Barnett.